CREDIT SUISSE AG/ - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 58 filers reported holding AKCEA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$7,125,000
+3229.4%
392,768
+2409.2%
0.00%
Q2 2020$214,000
-8.5%
15,653
-4.1%
0.00%
Q1 2020$234,000
-41.1%
16,327
-30.3%
0.00%
Q4 2019$397,000
+113.4%
23,422
+93.8%
0.00%
Q3 2019$186,000
-45.8%
12,085
-17.4%
0.00%
Q2 2019$343,000
-55.1%
14,630
-45.8%
0.00%
-100.0%
Q1 2019$764,000
+79.8%
26,975
+91.7%
0.00%
Q4 2018$425,000
+2.4%
14,071
+18.8%
0.00%
Q3 2018$415,000
+23.1%
11,841
-16.7%
0.00%
Q2 2018$337,000
-50.1%
14,223
-46.1%
0.00%
-100.0%
Q1 2018$676,000
+40.2%
26,365
-4.9%
0.00%
Q4 2017$482,000
+74.0%
27,734
+176.4%
0.00%
Q3 2017$277,00010,0330.00%
Other shareholders
AKCEA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Bellevue Group AG 3,204,244$45,821,0000.89%
Amia Capital LLP 21,337$305,0000.27%
Virtus ETF Advisers LLC 30,486$436,0000.18%
Motley Fool Asset Management LLC 59,972$858,0000.11%
Caption Management, LLC 81,600$1,168,0000.07%
Dynamic Technology Lab Private Ltd 16,826$241,0000.05%
Caption Management, LLC 57,000$816,0000.05%
ALPS ADVISORS INC 170,720$2,441,0000.04%
TUDOR INVESTMENT CORP ET AL 28,364$406,0000.04%
AIGEN INVESTMENT MANAGEMENT, LP 14,515$208,0000.03%
View complete list of AKCEA THERAPEUTICS INC shareholders